Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain · Delayed Price · Currency is EUR 54.15
+0.45 (0.84%)
Jul 17, 2026, 5:35 PM CET
BME:ROVI Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, BME:ROVI stock has a consensus rating of "Buy" and an average price target of €75.38. The average 1-year stock price forecast is 39.21% higher than the current stock price, while the lowest is €64.20 (+18.56%) and the highest is €84.00 (+55.12%).
Price Target: €75.38 (+39.21%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for BME:ROVI stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 4 | 4 | 4 | 4 | 3 |
| Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Hold | 2 | 3 | 3 | 4 | 4 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Maintains €83.50 → €64.20 | Hold | Maintains | €83.50 → €64.20 | +18.56% | May 14, 2026 |
| Kepler Capital | Kepler Capital | Buy Maintains €90.00 → €83.00 | Buy | Maintains | €90.00 → €83.00 | +53.28% | May 6, 2026 |
Financial Forecast
Revenue This Year
773.53M
from 743.48M
Increased by 4.04%
Revenue Next Year
898.80M
from 773.53M
Increased by 16.19%
EPS This Year
2.56
from 2.75
Decreased by -7.03%
EPS Next Year
3.47
from 2.56
Increased by 35.74%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.